{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-037609","form_type":"8-K","ticker":"ALIT","cik":"0001809104","company_name":"Alight, Inc. / Delaware","filed_at":"2025-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.067721+00:00","generated_at":"2026-05-17T20:55:06.210528+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Alight Q2 revenue down 2% to $528M; net loss $1B on goodwill impairment; reaffirms EBITDA guidance","bullets":["Revenue $528M, down 1.9% YoY; gross profit margin improved to 33.3% from 31.0%.","Net loss of $1,073M driven by $983M non-cash goodwill impairment in Health Solutions; adjusted EPS $0.10 vs $0.05.","Adjusted EBITDA $127M vs $105M; FY25 outlook: revenue $2,282M-$2,329M, adj. EBITDA $620M-$645M.","New wins with Thermo Fisher, Highmark, RGA, Trinity; partnership with Goldman Sachs Asset Management."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-037609","json":"https://secwatch.observer/filing/0001628280-25-037609.json","markdown":"https://secwatch.observer/filing/0001628280-25-037609.md","text":"https://secwatch.observer/filing/0001628280-25-037609.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1809104/000162828025037609/0001628280-25-037609-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1809104/000162828025037609/alit-20250805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T20:55:06.210528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}